(Q40837798)

24 September 2017

title

Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation (English)

1 reference

24 September 2017

1

1 reference

24 September 2017

2

Spooncer E

1 reference

24 September 2017

Wooley S

3

1 reference

24 September 2017

Dive C

4

1 reference

24 September 2017

Francis JM

5

1 reference

24 September 2017

Miyan J

6

1 reference

24 September 2017

Owen-Lynch PJ

7

1 reference

24 September 2017

Dexter TM

8

1 reference

24 September 2017

Whetton AD

9

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

19

1 reference

24 September 2017

issue

48

1 reference

24 September 2017

page(s)

5487-5497

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203940

24 September 2017

exact match

0 references

cites work

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

A functional analysis of p53 during early development of Xenopus laevis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

JNK targets p53 ubiquitination and degradation in nonstressed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

MEKK1/JNK signaling stabilizes and activates p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Expression of the GM-CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte-macrophage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Markers of mouse macrophage development detected by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

BCR-ABL accelerates C2-ceramide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Inactivation of p53 results in high rates of homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Functional and biochemical phenotype in relation to cellular age of differentiated neutrophils in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Regulation of ES cell differentiation by functional and conformational modulation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Interference with p53 protein inhibits hematopoietic and muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Biology of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

7 January 2021

A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

7 January 2021

Hemizygous expression of the wild-type p53 allele may confer a selective growth advantage before complete inactivation of the p53 gene in the progression of chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

7 January 2021

P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

7 January 2021

Analysis of the p53 and MDM-2 gene in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

7 January 2021

p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203940

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203940

1 reference

Dimensions Publication ID

24 September 2017

1010634852

0 references

1 reference